نتائج البحث - "Barry S. Skikne"

1

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase 3, placebo-controlled QUAZAR AML-001 trial

المصدر: Haematologica. 106:3240-3244

مصطلحات موضوعية: Oncology, Health related quality of life, medicine.medical_specialty, business.industry, Internal medicine, medicine, MEDLINE, Myeloid leukemia, Hematology, Placebo, business, Oral Azacitidine

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::cc56742deef2ae04ca2a891cfa3f2060
https://doi.org/10.3324/haematol.2021.279174

2

Management of adverse events in patients with acute myeloid leukemia in remission receiving oral azacitidine: experience from the phase 3 randomized QUAZAR AML-001 trial

المصدر: Journal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-14 (2021)
JOURNAL OF HEMATOLOGY & ONCOLOGY
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Journal of Hematology & Oncology

مصطلحات موضوعية: Male, Cancer Research, medicine.medical_specialty, Antimetabolites, Antineoplastic, Neutropenia, Gastrointestinal Diseases, Maintenance, Phases of clinical research, Administration, Oral, Placebo, Oral Azacitidine, Maintenance therapy, Internal medicine, medicine, Humans, Diseases of the blood and blood-forming organs, Adverse effect, Molecular Biology, RC254-282, Aged, Aged, 80 and over, Oral azacitidine, business.industry, Myelodysplastic syndromes, Research, Remission Induction, Disease Management, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Anemia, Hematology, Middle Aged, medicine.disease, Placebo Effect, Thrombocytopenia, Discontinuation, Leukemia, Myeloid, Acute, Oncology, Concomitant, Azacitidine, Female, Safety, RC633-647.5, business, CC-486

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e9e05abab8312fc9f61678ffcc1c4a0
https://doaj.org/article/643e4039c05b4d0693acd3685dcccc4b

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

3

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer

المؤلفون: Thai H. Ho, C.L. Beach, Eric Laille, Barry S. Skikne, Michael R. Savona, Kao Tai Tsai, Dale R. Shepard, Maen Abdelrahim, Mohammed M. Milhem, Hani M. Babiker, William Jeffery Edenfield, Joseph Aisner, Swaminathan P. Iyer

المصدر: Cancer Chemotherapy and Pharmacology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac474561c68318279391a8c405ec6a2
https://doi.org/10.1007/s00280-020-04037-9

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

4

CC-486 Improves Overall Survival (OS) and Relapse-Free Survival (RFS) for Patients with Acute Myeloid Leukemia (AML) in First Remission after Intensive Chemotherapy (IC), Regardless of Amount of Consolidation Received: Results from the Phase III QUAZAR AML-001 Maintenance Trial

المؤلفون: Hartmut Döhner, Keshava Kumar, C.L. Beach, Barry S. Skikne, Christopher Pocock, Gail J. Roboz, Dominik Selleslag, Andre C. Schuh, Qian Dong, Andrew H. Wei, Farhad Ravandi, Sergey N. Bondarenko, Hervé Dombret, Ignazia La Torre, Pau Montesinos

المصدر: Blood. 136:38-40

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Immunology, First remission, Myeloid leukemia, Cell Biology, Hematology, Intensive chemotherapy, Biochemistry, Relapse free survival, Internal medicine, medicine, Overall survival, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::5e2eeade1d7e44b70fc707e50b84e6b4
https://doi.org/10.1182/blood-2020-138498

5

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

المؤلفون: Richard Stone, Hartmut Döhner, Anna Dolnik, Lin Tang, C.L. Beach, Nora Tu, Kyle J. MacBeth, John F. Seymour, Lars Bullinger, Teresa Bernal del Castillo, Mark D. Minden, Valeria Santini, S. Songer, Barry S. Skikne, Haifa Kathrin Al-Ali, Hervé Dombret, Paresh Vyas

المصدر: Leukemia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::791ae212923df6f72bf29f28d348898b
https://doi.org/10.1038/s41375-018-0257-z

Find this article in full text from Springer Verlag.

Find this article in full text from ProQuest

6

Phase III, randomized, placebo-controlled trial of CC-486 (oral azacitidine) in patients with lower-risk myelodysplastic syndromes

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4292672c790570d7eb0a77b548d74e12
http://hdl.handle.net/2108/283551

7

Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission

المساهمون: Hematology laboratory, CCA - Cancer Treatment and quality of life

المصدر: New England Journal of Medicine, 383(26), 2526-2537. Massachussetts Medical Society
NEW ENGLAND JOURNAL OF MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Wei, A H, Döhner, H, Pocock, C, Montesinos, P, Afanasyev, B, Dombret, H, Ravandi, F, Sayar, H, Jang, J-H, Porkka, K, Selleslag, D, Sandhu, I, Turgut, M, Giai, V, Ofran, Y, Çakar, M K, de Sousa, A B, Rybka, J, Frairia, C, Borin, L, Beltrami, G, Čermák, J, Ossenkoppele, G J, la Torre, I, Skikne, B, Kumar, K, Dong, Q, Beach, C L, the QUAZAR AML-001 Trial Investigators & Roboz, G J 2020, ' Oral azacitidine maintenance therapy for acute myeloid leukemia in first remission ', New England Journal of Medicine, vol. 383, no. 26, pp. 2526-2537 . https://doi.org/10.1056/NEJMoa2004444